menu search

Algernon pharmaceuticals includes novel salt forms of dmt in its recent ip patent applications

Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) told investors that it believes the company has "m...

January 24, 2022, 8:22 am

Bofa securities: there's hardly any upside in curevac this year

Shares of CureVac N.V. (NASDAQ: CVAC) closed nearly 15% down on Friday after BofA Securities said there isn't much in the books this year for sharehol...

January 21, 2022, 4:28 pm

Bofa securities: there's hardly any upside in curevac this year

Shares of CureVac N.V. (NASDAQ: CVAC) closed nearly 15% down on Friday after BofA Securities said there isn't much in the books this year for sharehol...

January 21, 2022, 4:28 pm

Bofa securities: there's hardly any upside in curevac this year

Shares of CureVac N.V. (NASDAQ: CVAC) closed nearly 15% down on Friday after BofA Securities said there isn't much in the books this year for sharehol...

January 21, 2022, 4:28 pm

Hepion pharmaceuticals: facing the momentous year 2022

Hepion begins the crucial year 2022, where it will finally be determined whether CRV431 possesses anti-fibrotic/anti-inflammatory activity in NASH pat...

January 21, 2022, 12:37 pm

Hepion pharmaceuticals: facing the momentous year 2022

Hepion begins the crucial year 2022, where it will finally be determined whether CRV431 possesses anti-fibrotic/anti-inflammatory activity in NASH pat...

January 21, 2022, 12:37 pm

Hepion pharmaceuticals: facing the momentous year 2022

Hepion begins the crucial year 2022, where it will finally be determined whether CRV431 possesses anti-fibrotic/anti-inflammatory activity in NASH pat...

January 21, 2022, 12:37 pm

Why this analyst has increased confidence in inovio pharmaceuticals

Following the recent pullback in Inovio pharmaceuticals Inc.'s (NASDAQ:INO) shares, the stock valuation...

January 21, 2022, 11:50 am

Why this analyst has increased confidence in inovio pharmaceuticals

Following the recent pullback in Inovio pharmaceuticals Inc.'s (NASDAQ:INO) shares, the stock valuation...

January 21, 2022, 11:50 am

Why this analyst has increased confidence in inovio pharmaceuticals

Following the recent pullback in Inovio pharmaceuticals Inc.'s (NASDAQ:INO) shares, the stock valuation...

January 21, 2022, 11:50 am

Alnylam' reveals detailed 18-month data from vutrisiran trial in inherited disease

Alnylam pharmaceuticals Inc (NASDAQ: ALNY) has announced detailed data from HELIOS-A Phase 3 study o...

January 21, 2022, 9:23 am

Alnylam' reveals detailed 18-month data from vutrisiran trial in inherited disease

Alnylam pharmaceuticals Inc (NASDAQ: ALNY) has announced detailed data from HELIOS-A Phase 3 study o...

January 21, 2022, 9:23 am

Alnylam' reveals detailed 18-month data from vutrisiran trial in inherited disease

Alnylam pharmaceuticals Inc (NASDAQ: ALNY) has announced detailed data from HELIOS-A Phase 3 study o...

January 21, 2022, 9:23 am

Apollon formularies names dr archibald mcdonald as clinical trials director

Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...

January 21, 2022, 7:57 am

Apollon formularies names dr archibald mcdonald as clinical trials director

Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...

January 21, 2022, 7:57 am

Apollon formularies names dr archibald mcdonald as clinical trials director

Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...

January 21, 2022, 7:57 am

Aslan pharma kickstarts mid-stage atopic dermatitis trial, data expected in 2023

ASLAN pharmaceuticals Ltd (NASDAQ: ASLN) has screened the first patient in its Phase 2b dose-ranging...

January 21, 2022, 6:36 am

Aslan pharma kickstarts mid-stage atopic dermatitis trial, data expected in 2023

ASLAN pharmaceuticals Ltd (NASDAQ: ASLN) has screened the first patient in its Phase 2b dose-ranging...

January 21, 2022, 6:36 am

Aslan pharma kickstarts mid-stage atopic dermatitis trial, data expected in 2023

ASLAN pharmaceuticals Ltd (NASDAQ: ASLN) has screened the first patient in its Phase 2b dose-ranging...

January 21, 2022, 6:36 am

Opiant pharma starts dosing in opnt002 mid-stage study for alcohol use disorder

Opiant pharmaceuticals Inc (NASDAQ: OPNT) has dosed the first patient in Phase 2 trial of OPNT002, n...

January 21, 2022, 5:56 am


Search within

Pages Search Results: